Downgrades Dominate as Analysts Trim Targets

Analysts have been busy cutting, with target price reductions outnumbering upgrades across the latest round of changes.

The sharpest directional call is a fresh downgrade on ISRG. Intuitive Surgical lost a Buy rating from one analyst, shifting the consensus balance modestly toward Hold. At a $157 billion market cap, ISRG carries just 2.2% short interest as a percentage of free float, so bears remain scarce. The downgrade stands out precisely because Wall Street has been uniformly bullish on the robotics surgery leader for years.

MKC also drew a target cut, with the spice maker's average analyst price target slipping to $54.46 from $54.85. The stock faces pressure beyond the analyst desk. ORTEX Index Rebalance Radar assigns McCormick a 77% probability of deletion from the MSCI World index, with $735 million of forced selling potentially hitting over 4.4 days of average volume. The announcement is due 11 November.

BE saw multiple rating changes simultaneously. Bloom Energy's consensus flipped from two Buys to one Buy, with Holds rising. The stock still commands a $57 billion market cap after a strong run.

CRWD was the lone bright spot. CrowdStrike received a target price increase, edging the consensus target to $247. The cybersecurity firm remains the most bullishly covered name in the batch, with 37 Buy ratings against just one Sell.